Preclinical evidence for the use of <scp>anti‐Trop</scp> ‐2 antibody‐drug conjugate Sacituzumab govitecan in cerebral metastasized castration‐resistant prostate cancerRichard Weiten, Niklas Klümper|Cancer Medicine|2024Cited by 9